spacer
home > pmps > spring 2017 > partial to particles
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Partial to Particles

Dry powder inhalers (DPIs) are almost exclusively passive devices, relying on the energy supplied by the inhaling patient for dose dispersion. Consequently, their designs are crucial in determining the extent to which this limited energy supply aerosolises the formulation to a respirable particle size. With growing focus on particles towards the finer end of the size distribution, achieving consistent and effective dispersion with any given inhalation profile is becoming increasingly important.

The incorporation of a breath-actuated mechanism (BAM) has been shown to enhance the dispersion performance of DPIs. It works by inhibiting the release of the dose until the pressure drop across the device reaches a certain value, thereby promoting highly energetic dispersion and efficient delivery.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr David Lewis is Head of Laboratory at Chiesi’s Research Centre in Chippenham, UK, which he established in July 2009. He holds a BSc in Physics as well as an MSc and PhD in Aerosol Science from the University of Essex, UK. David has authored over 130 research publications within the fields of pharmaceutics, analytical chemistry and aerosol science, and is co-inventor of 30 patents relating to pressurised MDI formulations and devices.

After graduating from the University of Southampton, UK, Alan Tweedie worked for a year as a Quality Control Chemist at a UK biotechnology company. He then moved to Bristol, where he joined Vectura, a pharma firm specialising in inhalation therapy. As part of an early-stage feasibility team, Alan was involved in the manufacture and analysis of dry powder formulations, discovering a particular interest in the interactions that exist between the device and formulation. In 2011, he started working for Chiesi at the Chippenham Research Centre.

Francesca Mason graduated from the University of Bradford, UK, in 2010 with a degree in Chemistry, Pharmaceuticals and Forensic Science. She joined Chiesi in 2011 at the Chippenham Research Centre and has now been a Scientist for more than five years. Francesca has predominately worked within the atomisation team involved in creating novel and innovative formulation and technology platforms for inhaled drug delivery.
spacer
Dr David Lewis
spacer
spacer
spacer
Alan Tweedle
spacer
spacer
spacer
Francesca Mason
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

E Ink and Faubel Unveil the Med Label to Revolutionize the Clinical Trial Supply Chain

E Ink® Holdings, "E Ink" (8069.TW), the leading innovator of electronic ink technology and Faubel & Co. Nachf. GmbH, a proven supplier to the pharmaceutical and chemical industry, announced the availability of the Faubel-Med® Label, a smart label for investigational medicinal products. The Med Label features E Ink’s low-voltage film technology, bringing display modules and new system designs to pharmaceutical packaging.
More info >>

White Papers

The Key To Tableting Success: How To Choose The Right Tooling

Natoli Engineering Company, Inc.

Choosing the right tooling can increase tablet output, decrease waste and ultimately determine the success of a product launch.
More info >>

 
Industry Events

BioPharm America 2018

5-6 September 2018, Hynes Convention Center

BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement